Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Urologic Pharmacology, An Issue of Urologic Clinics
- 1st Edition, Volume 49-2 - April 16, 2022
- Editor: Craig V. Comiter
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 8 4 9 2 6 - 5
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 4 9 2 7 - 2
In this issue of Urologic Clinics of North America, guest editor Dr. Craig V. Comiter brings his considerable expertise to the topic of Urologic Pharmacology. Medical therapies… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of Urologic Clinics of North America, guest editor Dr. Craig V. Comiter brings his considerable expertise to the topic of Urologic Pharmacology. Medical therapies for benign prostatic hyperplasia, erectile dysfunction, hypogonadism, overactive bladder, and prostate cancer are widely available, and a basic understanding of the pharmacology of existing treatment options are necessary to avoid complications and maximize efficacy associated with patient outcomes. In this issue, top experts in the field provide current clinical information to help urologists effectively and quickly treat patients.
-
Contains 14 relevant, practice-oriented topics including medical treatment for benign prostatic hyperplasia, medical treatment for urinary tract infections, nutraceuticals and phytotherapy in men’s health, hormonal therapy for prostate cancer, medical treatment of female sexual dysfunction, and more.
-
Provides in-depth clinical reviews on urologic pharmacology, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Foreword
- Preface
- Medical Treatment of Hypogonadism in Men
- Key points
- Introduction
- Definitions and background
- Pharmacologic management of testosterone deficiency syndrome
- Summary
- Clinics care points
- Pharmacotherapy for Erectile Dysfunction in 2021 and Beyond
- Key points
- Introduction
- Molecular mechanisms of erection
- Oral pharmacotherapy for erectile dysfunction
- Injection pharmacotherapy for erectile dysfunction
- Intraurethral pharmacotherapy for erectile dysfunction
- Combination therapy
- Future directions
- Summary
- Medical Treatment of Disorders of Ejaculation
- Key points
- Introduction
- Physiology of orgasm and ejaculation
- Premature ejaculation
- Delayed ejaculation
- Other ejaculatory disorders
- Summary
- Clinics care points
- Medical Treatment of Benign Prostatic Hyperplasia
- Key points
- Introduction
- Alpha-adrenergic antagonism
- 5-alpha reductase inhibition
- Anticholinergics
- Phosphodiesterase type 5 inhibition
- Beta-3 adrenergic agonism
- Phytotherapy
- Summary and suggestions
- Clinics care points
- Nutraceuticals and Phytotherapy in Men's Health: Antioxidants, Pro-oxidants, and a Novel Opportunity for Lifestyle Changes
- Key points
- Introduction
- Nutraceuticals and the greater perspective
- BPH and herbal conundrums
- Erectile dysfunction (ED) and nitric oxide options and limitations
- Male infertility: anti-versus pro-oxidants
- Prostate cancer: less is more
- Antiparasitic alternative products for prostate cancer?
- Testosterone replacement risks: pills versus RX versus lifestyle
- Summary
- Clinics care points
- Medical Treatment of Overactive Bladder
- Key points
- Introduction
- Epidemiology and cause
- Pathophysiology
- Treatments
- Antimuscarinics/anticholinergics
- Concerns with long-term anticholinergic use
- Beta-3 agonists
- Antidepressants
- Other
- Future pharmacologic treatments and combination therapies
- Combination therapy
- Novel therapeutic targets
- Summary
- Clinics care points
- Conflicts of interest
- Chemodenervation in Urology
- Key points
- Background
- Structure of botulinum toxin
- Mechanism of action
- Effect of botulinum toxin
- Clinical usage
- Administration
- Side effects and considerations
- Summary
- Clinics care points
- Supplementary data
- Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
- Key points
- Introduction
- Oral pharmacotherapies
- Intravesical pharmacotherapies
- Intradetrusor onabotulinum toxin A
- Pharmacotherapies in clinical development
- Meta-analysis of pharmacotherapies for IC/BPS
- Summary
- Disclosure
- Clinics care points
- Medical Treatment for Urinary Tract Infections
- Introduction
- Epidemiology
- Pathophysiology
- Uncomplicated versus complicated urinary tract infections
- Treatment of symptomatic urinary tract infections
- Treatment of uncomplicated urinary tract infections
- Treatment of complicated urinary tract infections
- Treatment of fungal urinary tract infections
- Asymptomatic bacteriuria
- Antimicrobial resistance
- Nonantimicrobial treatment of acute urinary tract infection
- Urinary tract infection prevention
- Nonantimicrobial prophylaxis
- Future directions
- Summary
- Clinics care points
- Conflicts of interest
- Medical Treatment of Female Sexual Dysfunction
- Key points
- Introduction
- Sex hormone milieu
- Central nervous system circuitries
- Neurovascular/neuromuscular system
- Future directions
- Summary
- Author contributions
- Disclosure statement
- Hormone Treatment of Prostate Cancer:: Evidence for Usage and Safety
- Key points
- Background
- Pharmacotherapy
- Discussion
- Immunotherapy and Checkpoint Inhibitors in Urologic Cancer
- Key points
- Introduction
- Penile cancer immunotherapy
- Summary
- Medical Treatment and Prevention of Urinary Stone Disease
- Key points
- Background
- Pathophysiology
- Medical therapies for stone prevention
- Medical therapies for stone treatment
- Summary
- Immunosuppression Therapy in Kidney Transplantation
- Key points
- Introduction
- Epidemiology of kidney transplantation
- Transplant immunology – the alloimmune response
- Aging and immunosuppression
- Summary
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 49-2
- Published: April 16, 2022
- Imprint: Elsevier
- Hardback ISBN: 9780323849265
- eBook ISBN: 9780323849272
CC
Craig V. Comiter
Affiliations and expertise
Associate Professor, Department of Urology, Stanford University Medical Center, Stanford, CA